Department of Anaesthesiology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands; Amsterdam UMC Centre for Sustainable Healthcare, Amsterdam UMC, Amsterdam, The Netherlands.
Department of Anaesthesiology, Noordwest Ziekenhuisgroep, Alkmaar, The Netherlands.
Br J Anaesth. 2024 Dec;133(6):1419-1426. doi: 10.1016/j.bja.2024.02.011. Epub 2024 Mar 11.
Nitrous oxide (NO) is a common adjuvant to general anaesthesia. It is also a potent greenhouse gas and causes ozone depletion. We sought to quantify the influence of NO as an adjuvant to general anaesthesia on postoperative patient outcomes.
We searched Medline, EMBASE, and Cochrane Central for works published from inception to July 6, 2023. RCTs comparing general anaesthesia with or without NO were included. Risk ratios (RRs) and standardised mean differences (SMDs) were calculated, along with 95% confidence intervals (CIs), using a random-effects model. Outcomes were derived from the Standardised Endpoints for Perioperative Medicine (StEP) outcome set. Primary outcomes were mortality and organ-related morbidity, and secondary outcomes were anaesthetic and surgical morbidity.
Of 3305 records, 179 full-text articles were assessed, and 71 RCTs, totalling 22 147 patients, were included in the meta-analysis. Addition of NO to general anaesthesia did not influence postoperative mortality or most morbidity outcomes. NO increased the incidence of atelectasis (RR 1.62, 95% CI 1.24 to 2.12) and postoperative nausea and vomiting (RR 1.27, 95% CI 1.15 to 1.40), and decreased intraoperative opioid consumption (SMD -0.19, 95% CI -0.35 to -0.04) and time to extubation (MD -2.17 min, 95% CI -3.32 to -1.03 min).
NO did not influence postoperative mortality or most morbidity outcomes. Considering the environmental effects of NO, these findings confirm that current policy recommendations to limit its use do not affect patient safety.
PROSPERO CRD42023443287.
氧化亚氮(NO)是全身麻醉的常用辅助药物。它也是一种强效的温室气体,会导致臭氧消耗。我们旨在量化 NO 作为全身麻醉辅助药物对术后患者结局的影响。
我们在 Medline、EMBASE 和 Cochrane Central 中检索了从成立到 2023 年 7 月 6 日发表的文献。纳入了比较全身麻醉加用或不加用 NO 的 RCT。使用随机效应模型计算风险比(RR)和标准化均数差(SMD),并计算 95%置信区间(CI)。结果源自围手术期医学标准化结局(StEP)结局集。主要结局为死亡率和器官相关发病率,次要结局为麻醉和手术发病率。
在 3305 条记录中,评估了 179 篇全文文章,共有 71 项 RCT 纳入了 22147 名患者的 meta 分析。全身麻醉加用 NO 并不影响术后死亡率或大多数发病率结局。NO 增加了肺不张(RR 1.62,95%CI 1.24 至 2.12)和术后恶心呕吐(RR 1.27,95%CI 1.15 至 1.40)的发生率,并减少了术中阿片类药物的消耗(SMD-0.19,95%CI-0.35 至-0.04)和拔管时间(MD-2.17 分钟,95%CI-3.32 至-1.03 分钟)。
NO 并不影响术后死亡率或大多数发病率结局。考虑到 NO 的环境影响,这些发现证实了当前限制其使用的政策建议不会影响患者安全。
PROSPERO CRD42023443287。